We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Kappa-PET Imaging and Naltrexone in Alcohol Drinking Behaviors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01625611
Recruitment Status : Recruiting
First Posted : June 21, 2012
Last Update Posted : September 25, 2017
Information provided by (Responsible Party):
Yale University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : June 2018
  Estimated Study Completion Date : June 2018